Dr. Christopher A. Perro, MD

Dr. Perro practices at Etmc Physician Group Inc. in Tyler, Texas.

Dr. Perro's NPI, 1346462496, was assigned on May 2, 2007. Dr. Perro graduated from Joe R. & Teresa Lozano Long School of Medicine in 2006. Dr. Perro holds Texas license Q7259.

Dr. Perro's primary practice is Etmc Physician Group Inc., at 2210 3 Lakes Pkwy, Tyler, TX 75703 in Smith County. The practice phone is (903) 590-5611.

Dr. Perro's primary practice is Etmc Physician Group Inc. in Tyler, Texas. Dr. Perro is also affiliated with UT Health Tyler. The medical group on file is UT Health East Texas Physicians. Dmand AI also links Dr. Perro to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Perro practices, 7 sites in all. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Dr. Perro's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Dr. Perro is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Perro's licenses on file in 4 states: Texas, California, Louisiana and Illinois.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Perro treats.

CMS data shows 882 Medicare services from Dr. Perro across 8 procedure codes in 2024, for 343 Medicare patients. Medicare paid $79,134 for them. Every service was in an office.

CMS counts 343 Medicare patients who saw Dr. Perro in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Perro's median patient age at 69, with 59% women.

In 2024, Dr. Perro wrote 1,811 Medicare Part D claims for 515 patients. 99% of them were for generic drugs. CMS names the drug for 1,675 of them, across 19 drugs with 11 or more claims each, at $29,424 in total drug cost. In 2023, CMS named 1,324 claims across 16 drugs.

Dr. Perro accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Perro in 2010. The most frequent topics are Immunohistochemistry. Dr. Perro's most frequent co-authors are Jennifer Ray Bunch, MD and Leonard P. Rybak, MD.

CMS Open Payments shows 71 general payments to Dr. Perro from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Allergan Inc. paid the most, $935.

Dmand AI lists 1 award for Dr. Perro, most recently Meritorious Service Medal in 2015.

Dr. Perro graduated from Joe R. & Teresa Lozano Long School of Medicine in 2006. Dr. Perro is a member of AAFPRS, NHS, ACS and TMA.

Dr. Perro is in network with 21 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.